Income Statement Pilulka Lékárny

Stocks

PINK

CZ0009009874

Drug Retailers

End-of-day quote Prague S.E. 19/08/2026			5-day change	1st Jan Change
118.00 ^CZK	-2.48%		+8.26%	-30.59%

15/06	Pilulka Lékárny a.s. Auditor Raises 'Going Concern' Doubt	CI
15/06	Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

6e72.47XsaZd1RzF3DSc_o3XjUGv1KvB3XqpVonvcLbkWhBQ.1fOpP_MTIXoGQENT2hGgKjqGB4EONvA8m0qqAP1F63qs2bYBzj01VS5vSA

Published financial data: PILULKA LÉKÁRNY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	238.03Cr	244.73Cr	213.18Cr	130.42Cr	88Cr
Total Revenues	238.03Cr	244.73Cr	213.18Cr	130.42Cr	88Cr
Cost of Goods Sold, Total	236.68Cr	244.7Cr	183.45Cr	112.08Cr	75Cr
Gross Profit	1.35Cr	3L	30Cr	18Cr	13Cr
Selling General & Admin Expenses, Total	-	-	36Cr	23Cr	18Cr
Depreciation & Amortization - (IS)	-	-	7.39Cr	7.29Cr	2.83Cr
Amortization of Goodwill and Intangible Assets - (IS)	1.22Cr	23.57L	-	-	-
Other Operating Expenses	1.54Cr	4.57Cr	75.1L	-86.89L	-6.19Cr
Other Operating Expenses, Total	2.76Cr	4.8Cr	45Cr	29Cr	15Cr
Operating Income	-1.41Cr	-4.77Cr	-15Cr	-11Cr	-1.65Cr
Interest Expense, Total	-8L	-47.64L	-1.05Cr	-1.23Cr	-1.7Cr
Interest And Investment Income	7L	2L	49T	6T	6T
Net Interest Expenses	-63T	-45.58L	-1.04Cr	-1.23Cr	-1.7Cr
Other Non Operating Income (Expenses)	-1.06Cr	-1.17Cr	-1.69Cr	-1.27Cr	-67.78L
EBT, Excl. Unusual Items	-2.47Cr	-6.4Cr	-18Cr	-13Cr	-4.02Cr
Gain (Loss) On Sale Of Assets	-	-	19T	85.56L	17.22L
EBT, Incl. Unusual Items	-2.47Cr	-6.4Cr	-18Cr	-13Cr	-3.85Cr
Income Tax Expense	10L	17.47L	4T	-	1L
Earnings From Continuing Operations	-2.57Cr	-6.58Cr	-18Cr	-13Cr	-3.86Cr
Net Income to Company	-2.57Cr	-6.58Cr	-18Cr	-13Cr	-3.86Cr
Minority Interest	2L	8L	9L	6L	-3L
Net Income - (IS)	-2.55Cr	-6.49Cr	-17Cr	-13Cr	-3.89Cr
Net Income to Common Incl Extra Items	-2.55Cr	-6.49Cr	-17Cr	-13Cr	-3.89Cr
Net Income to Common Excl. Extra Items	-2.55Cr	-6.49Cr	-17Cr	-13Cr	-3.89Cr
Per Share Items
Net EPS - Basic	-	-25.76	-64.63	-46.46	-14.36
Basic EPS - Continuing Operations	-	-25.76	-64.63	-46.46	-14.36
Basic Weighted Average Shares Outstanding	-	25.21L	27.07L	27.07L	27.07L
Net EPS - Diluted	-	-25.76	-64.63	-46.46	-14.36
Diluted EPS - Continuing Operations	-	-25.76	-64.63	-46.46	-14.36
Diluted Weighted Average Shares Outstanding	-	25.21L	27.07L	27.07L	27.07L
Normalized Basic EPS	-	-15.54	-40.27	-30.92	-9.38
Normalized Diluted EPS	-	-15.54	-40.27	-30.92	-9.38
Supplemental Items
EBITDA	82.62L	-2.99Cr	-13Cr	-9.03Cr	-15.21L
EBITA	-10.27L	-4.46Cr	-15Cr	-11Cr	-1.41Cr
EBIT	-1.41Cr	-4.77Cr	-15Cr	-11Cr	-1.65Cr
Effective Tax Rate - (Ratio)	-4.03	-2.73	-0	-	-0.28
Total Current Taxes	9L	-1T	-	-	1L
Total Deferred Taxes	1L	17.48L	4T	-	-
Normalized Net Income	-1.52Cr	-3.92Cr	-11Cr	-8.37Cr	-2.54Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.16Cr	2.07Cr	1.08Cr	1.02Cr	1.56Cr
Total Cash And Short Term Investments	7.16Cr	2.07Cr	1.08Cr	1.02Cr	1.56Cr
Accounts Receivable, Total	16Cr	14Cr	13Cr	6.74Cr	3.93Cr
Other Receivables	2.84Cr	5.51Cr	3.87Cr	1.11Cr	2.35Cr
Total Receivables	18Cr	20Cr	17Cr	7.85Cr	6.28Cr
Inventory	16Cr	19Cr	9.62Cr	5.47Cr	6.34Cr
Prepaid Expenses	-	-	-	-	19.12L
Other Current Assets, Total	-	-	41.66L	27.23L	-
Total Current Assets	41Cr	41Cr	28Cr	15Cr	14Cr
Gross Property Plant And Equipment	8.15Cr	11Cr	11Cr	7.15Cr	4.73Cr
Accumulated Depreciation	-1.91Cr	-3.25Cr	-4.78Cr	-5.04Cr	-3.83Cr
Net Property Plant And Equipment	6.24Cr	7.44Cr	5.76Cr	2.11Cr	90.05L
Long-term Investments	40.5L	91.75L	-	-	-
Goodwill	2.69Cr	2.38Cr	2.13Cr	1.9Cr	1.67Cr
Other Intangibles, Total	8.18Cr	8.96Cr	6.73Cr	3.9Cr	2.27Cr
Loans Receivable Long-Term	-	-	51.24L	51.26L	-
Other Long-Term Assets, Total	23.75L	37.76L	83.86L	68.77L	49.82L
Total Assets	59Cr	61Cr	44Cr	24Cr	20Cr
Liabilities
Accounts Payable, Total	-	-	28Cr	16Cr	15Cr
Accrued Expenses, Total	1.59Cr	84.73L	1.71Cr	9.42Cr	53.23L
Short-term Borrowings	-	-	5.21Cr	4.48Cr	5.29Cr
Current Portion of Long-Term Debt	-	-	2.12Cr	12L	12L
Current Income Taxes Payable	-	-	1.13Cr	77.32L	16.71L
Other Current Liabilities	35Cr	43Cr	1.51Cr	1.73Cr	12Cr
Total Current Liabilities	36Cr	44Cr	40Cr	33Cr	33Cr
Long-Term Debt	-	-	36.75L	24L	12L
Other Non Current Liabilities	2.15Cr	2.49Cr	90.95L	47.29L	38.07L
Total Liabilities	39Cr	47Cr	41Cr	33Cr	34Cr
Common Stock, Total	25L	25.21L	27.07L	27.07L	27.07L
Additional Paid In Capital	39Cr	39Cr	28Cr	28Cr	28Cr
Retained Earnings	-19Cr	-25Cr	-43Cr	-55Cr	-59Cr
Comprehensive Income and Other	-	-	18Cr	18Cr	18Cr
Total Common Equity	20Cr	14Cr	3.28Cr	-9.4Cr	-13Cr
Minority Interest	-3L	-12.06L	-21.39L	-27.73L	-40.59L
Total Equity	20Cr	14Cr	3.07Cr	-9.67Cr	-14Cr
Total Liabilities And Equity	59Cr	61Cr	44Cr	24Cr	20Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	25.21L	27.07L	27.07L	27.07L
ECS Total Common Shares Outstanding	-	25.21L	27.07L	27.07L	27.07L
Book Value / Share	-	55.59	12.14	-34.72	-49.45
Tangible Book Value	9.57Cr	2.68Cr	-5.58Cr	-15Cr	-17Cr
Tangible Book Value Per Share	-	10.61	-20.62	-56.16	-64.02
Total Debt	0	0	7.7Cr	4.84Cr	5.53Cr
Net Debt	-7.16Cr	-2.07Cr	6.62Cr	3.83Cr	3.97Cr
Minority Interest, Total (Incl. Fin. Div)	-3L	-12.06L	-21.39L	-27.73L	-40.59L
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	-	-	1L	-	-
Inventories - Finished Goods, Total	16Cr	19Cr	9.6Cr	5.47Cr	6.34Cr
Buildings, Total	29.01L	28.78L	10.57L	10.71L	3L
Machinery, Total	6.05Cr	8.76Cr	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1L	23T	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-2.55Cr	-6.49Cr	-17Cr	-13Cr	-3.89Cr
Depreciation & Amortization - CF	92.89L	1.47Cr	2.03Cr	1.73Cr	1.26Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.3Cr	31.84L	25.27L	23.57L	23.57L
Depreciation & Amortization, Total	2.23Cr	1.79Cr	2.28Cr	1.96Cr	1.5Cr
Amortization of Deferred Charges, Total - (CF)	1.26Cr	3.53Cr	5.36Cr	4.7Cr	2.17Cr
(Gain) Loss From Sale Of Asset	52T	95T	19T	34.14L	31.2L
Other Operating Activities, Total	90.07L	-55.25L	16T	56.62L	-93.46L
Change In Accounts Receivable	-2.82Cr	-1.41Cr	2.39Cr	9.33Cr	1.8Cr
Change In Inventories	-6.46Cr	-3.2Cr	9.1Cr	3.97Cr	-77.73L
Change In Accounts Payable	9.9Cr	2.51Cr	-5.08Cr	-13Cr	-2.22Cr
Cash from Operations	2.47Cr	-3.81Cr	-3.43Cr	-4.5Cr	-2.04Cr
Capital Expenditure	-8.21Cr	-7.68Cr	-3.56Cr	-2.01Cr	-
Sale of Property, Plant, and Equipment	52T	95T	19T	85.56L	28.04L
Cash from Investing	-8.21Cr	-7.67Cr	-3.56Cr	-1.15Cr	28.04L
Long-Term Debt Issued, Total	-	46.58L	-	6.42Cr	1.6Cr
Total Debt Issued	-	46.58L	-	6.42Cr	1.6Cr
Long-Term Debt Repaid, Total	-32.63L	-	-11.01L	-	-
Total Debt Repaid	-32.63L	-	-11.01L	-	-
Issuance of Common Stock	-	21T	6.74Cr	-	-
Cash from Financing	-32.63L	46.79L	6.63Cr	6.42Cr	1.6Cr
Foreign Exchange Rate Adjustments	5L	5L	4L	-10.78L	-10L
Net Change in Cash	-6.02Cr	-11Cr	-31.7L	65.78L	-25.79L
Supplemental Items
Cash Interest Paid	63T	47.64L	1.05Cr	1.23Cr	1.7Cr
Levered Free Cash Flow	-	-2.25Cr	61.54L	6.13Cr	1.87Cr
Unlevered Free Cash Flow	-	-1.95Cr	1.27Cr	6.9Cr	2.93Cr
Change In Net Working Capital	-	-3.39Cr	-6.47Cr	-9.11Cr	-29.57L
Net Debt Issued / Repaid	-32.63L	46.58L	-11.01L	6.42Cr	1.6Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	-4.99	-17.76	-20.29	-4.74
Return on Total Capital	-	-17.4	-56.04	-231.28	15.74
Return On Equity %	-	-38.34	-207.35	382.73	32.92
Return on Common Equity	-	-37.7	-202.26	411.4	34.12
Margin Analysis
Gross Profit Margin %	0.57	0.01	13.95	14.07	14.9
SG&A Margin	-	-	17.1	17.57	20.62
EBITDA Margin %	0.35	-1.22	-5.9	-6.92	-0.17
EBITA Margin %	-0.04	-1.82	-6.85	-8.25	-1.61
EBIT Margin %	-0.59	-1.95	-6.97	-8.43	-1.88
Income From Continuing Operations Margin %	-1.08	-2.69	-8.25	-9.69	-4.41
Net Income Margin %	-1.07	-2.65	-8.21	-9.64	-4.43
Net Avail. For Common Margin %	-1.07	-2.65	-8.21	-9.64	-4.43
Normalized Net Income Margin	-0.64	-1.6	-5.11	-6.42	-2.9
Levered Free Cash Flow Margin	-	-0.92	0.29	4.7	2.13
Unlevered Free Cash Flow Margin	-	-0.8	0.6	5.29	3.34
Asset Turnover
Asset Turnover	-	4.1	4.08	3.85	4.03
Fixed Assets Turnover	-	35.78	32.31	33.12	58.15
Receivables Turnover (Average Receivables)	-	16.39	15.98	13.21	16.42
Inventory Turnover (Average Inventory)	-	14.29	12.95	14.85	12.63
Short Term Liquidity
Current Ratio	1.13	0.92	0.71	0.45	0.44
Quick Ratio	0.7	0.49	0.45	0.27	0.24
Operating Cash Flow to Current Liabilities	0.07	-0.09	-0.09	-0.14	-0.06
Days Sales Outstanding (Average Receivables)	-	22.27	22.83	27.71	22.24
Days Outstanding Inventory (Average Inventory)	-	25.54	28.19	24.64	28.9
Average Days Payable Outstanding	-	-	64.79	74.79	75.19
Cash Conversion Cycle (Average Days)	-	-	-13.77	-22.44	-24.05
Long Term Solvency
Total Debt/Equity	-	-	250.77	-50.08	-40.1
Total Debt / Total Capital	-	-	71.49	-100.31	-66.95
LT Debt/Equity	-	-	11.97	-2.48	-0.87
Long-Term Debt / Total Capital	-	-	3.41	-4.97	-1.45
Total Liabilities / Total Assets	65.36	77.07	93.02	140.76	169.95
EBIT / Interest Expense	-18.08	-10.02	-14.18	-8.91	-0.97
EBITDA / Interest Expense	10.63	-6.27	-12	-7.32	-0.09
(EBITDA - Capex) / Interest Expense	-95.07	-22.39	-15.4	-8.95	-0.09
Total Debt / EBITDA	-	-	-0.61	-0.54	-36.36
Net Debt / EBITDA	-8.67	0.69	-0.53	-0.42	-26.07
Total Debt / (EBITDA - Capex)	-	-	-0.48	-0.44	-36.36
Net Debt / (EBITDA - Capex)	0.97	0.19	-0.41	-0.35	-26.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	2.81	-12.89	-38.82	-32.8
Gross Profit, 1 Yr. Growth %	-	-97.98	-25.8	-38.3	-28.82
EBITDA, 1 Yr. Growth %	-	-461.74	320.32	-28.21	-98.32
EBITA, 1 Yr. Growth %	-	4.24T	227.57	-26.35	-86.87
EBIT, 1 Yr. Growth %	-	239.76	211.03	-26.01	-85
Earnings From Cont. Operations, 1 Yr. Growth %	-	156.17	167.46	-28.14	-69.44
Net Income, 1 Yr. Growth %	-	154.71	169.4	-28.12	-69.09
Normalized Net Income, 1 Yr. Growth %	-	157.01	177.73	-23.21	-69.66
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	150.92	-28.12	-69.09
Accounts Receivable, 1 Yr. Growth %	-	-8.98	-4.89	-48.13	-41.69
Inventory, 1 Yr. Growth %	-	20.58	-48.63	-43.08	15.78
Net Property, Plant and Equip., 1 Yr. Growth %	-	19.09	-22.5	-63.32	-57.4
Total Assets, 1 Yr. Growth %	-	2.86	-27.44	-46.02	-16.93
Tangible Book Value, 1 Yr. Growth %	-	-72.03	-308.54	172.39	14
Common Equity, 1 Yr. Growth %	-	-31.43	-76.56	-386.11	42.42
Cash From Operations, 1 Yr. Growth %	-	-254.64	-10.12	31.21	-54.6
Capital Expenditures, 1 Yr. Growth %	-	-6.53	-53.59	-43.7	-
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-106.76	895.52	-69.5
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-114.44	442.88	-57.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-5.36	-27	-35.88
Gross Profit, 2 Yr. CAGR %	-	-	368.98	-32.34	-33.73
EBITDA, 2 Yr. CAGR %	-	-	290.13	73.71	-89
EBITA, 2 Yr. CAGR %	-	-	1.09T	55.33	-68.9
EBIT, 2 Yr. CAGR %	-	-	225.18	51.7	-66.69
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	161.75	38.63	-53.14
Net Income, 2 Yr. CAGR %	-	-	161.95	39.15	-52.86
Normalized Net Income, 2 Yr. CAGR %	-	-	167.37	46.04	-51.73
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	34.3	-52.86
Accounts Receivable, 2 Yr. CAGR %	-	-	-8.8	-29.76	-45
Inventory, 2 Yr. CAGR %	-	-	-21.29	-45.93	-18.82
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-3.93	-46.68	-60.47
Total Assets, 2 Yr. CAGR %	-	-	-13.61	-37.42	-33.04
Tangible Book Value, 2 Yr. CAGR %	-	-	-23.63	138.33	76.22
Common Equity, 2 Yr. CAGR %	-	-	-59.91	-18.11	101.86
Cash From Operations, 2 Yr. CAGR %	-	-	17.9	8.6	-22.82
Capital Expenditures, 2 Yr. CAGR %	-	-	-34.14	-48.89	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-17.94	74.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-11.47	51.86
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-18.17	-28.99
Gross Profit, 3 Yr. CAGR %	-	-	-	138.52	-31.18
EBITDA, 3 Yr. CAGR %	-	-	-	121.9	-62.95
EBITA, 3 Yr. CAGR %	-	-	-	371.38	-31.83
EBIT, 3 Yr. CAGR %	-	-	-	98.52	-29.86
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	70.12	-16.26
Net Income, 3 Yr. CAGR %	-	-	-	70.22	-15.72
Normalized Net Income, 3 Yr. CAGR %	-	-	-	76.4	-13.5
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-17.7
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-24.44	-33.98
Inventory, 3 Yr. CAGR %	-	-	-	-29.35	-30.31
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-30.3	-50.52
Total Assets, 3 Yr. CAGR %	-	-	-	-26.14	-31.22
Tangible Book Value, 3 Yr. CAGR %	-	-	-	16.69	86.39
Common Equity, 3 Yr. CAGR %	-	-	-	-22.82	-1.52
Cash From Operations, 3 Yr. CAGR %	-	-	-	22.18	-18.8
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-37.49	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-30.69